Tag Archives: NASDAQ:CBIO

The President & CEO of Catalyst Biosciences is Exercising Options

Today it was reported that the President & CEO of Catalyst Biosciences (CBIO – Research Report), USMAN NASSIM, exercised options to buy 5,000 CBIO shares at $4.63 a share, for a total transaction value of $23.15K. This recent transaction increases

LifeSci Capital Gives a Buy Rating to Catalyst Biosciences (CBIO)

In a report issued on March 4, Sam Slutsky from LifeSci Capital assigned a Buy rating to Catalyst Biosciences (CBIO – Research Report), with a price target of $16.00. The company’s shares closed last Thursday at $6.19. According to TipRanks.com,

Catalyst Biosciences (CBIO) Gets a Buy Rating from Raymond James

Raymond James analyst David Novak maintained a Buy rating on Catalyst Biosciences (CBIO – Research Report) on July 13 and set a price target of $20.00. The company’s shares closed last Wednesday at $5.56. According to TipRanks.com, Novak is a

LifeSci Capital Keeps a Buy Rating on Catalyst Biosciences (CBIO)

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Catalyst Biosciences (CBIO – Research Report), with a price target of $18.00. The company’s shares closed last Thursday at $5.27. According to TipRanks.com, Slutsky is

LifeSci Capital Maintains Their Buy Rating on Catalyst Biosciences (CBIO)

In a report issued on July 13, Sam Slutsky from LifeSci Capital maintained a Buy rating on Catalyst Biosciences (CBIO – Research Report), with a price target of $19.00. The company’s shares closed last Tuesday at $5.88. According to TipRanks.com,

JonesTrading Keeps Their Buy Rating on Catalyst Biosciences (CBIO)

JonesTrading analyst Matthew Cross reiterated a Buy rating on Catalyst Biosciences (CBIO – Research Report) today and set a price target of $23.00. The company’s shares closed last Monday at $7.87. According to TipRanks.com, Cross is a 5-star analyst with